These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

641 related articles for article (PubMed ID: 17041136)

  • 1. Helicobacter pylori persistence: an overview of interactions between H. pylori and host immune defenses.
    Algood HM; Cover TL
    Clin Microbiol Rev; 2006 Oct; 19(4):597-613. PubMed ID: 17041136
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of genome diversity and immune evasion in persistent infection with Helicobacter pylori.
    Cooke CL; Huff JL; Solnick JV
    FEMS Immunol Med Microbiol; 2005 Jul; 45(1):11-23. PubMed ID: 15949928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune responses to Helicobacter pylori colonization: mechanisms and clinical outcomes.
    Portal-Celhay C; Perez-Perez GI
    Clin Sci (Lond); 2006 Mar; 110(3):305-14. PubMed ID: 16464172
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of persistence, innate immune activation and immunomodulation by the gastric pathogen Helicobacter pylori.
    Zhang X; Arnold IC; Müller A
    Curr Opin Microbiol; 2020 Apr; 54():1-10. PubMed ID: 32007716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Evasion Strategies and Persistence of Helicobacter pylori.
    Mejías-Luque R; Gerhard M
    Curr Top Microbiol Immunol; 2017; 400():53-71. PubMed ID: 28124149
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Strategies used by
    Abadi ATB
    World J Gastroenterol; 2017 Apr; 23(16):2870-2882. PubMed ID: 28522905
    [No Abstract]   [Full Text] [Related]  

  • 7. Downregulated regulatory T cell function is associated with increased peptic ulcer in Helicobacter pylori-infection.
    Bagheri N; Shirzad H; Elahi S; Azadegan-Dehkordi F; Rahimian G; Shafigh M; Rashidii R; Sarafnejad A; Rafieian-Kopaei M; Faridani R; Tahmasbi K; Kheiri S; Razavi A
    Microb Pathog; 2017 Sep; 110():165-175. PubMed ID: 28666843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular cross-talk between Helicobacter pylori and human gastric mucosa.
    Ricci V; Romano M; Boquet P
    World J Gastroenterol; 2011 Mar; 17(11):1383-99. PubMed ID: 21472096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune evasion strategies used by Helicobacter pylori.
    Lina TT; Alzahrani S; Gonzalez J; Pinchuk IV; Beswick EJ; Reyes VE
    World J Gastroenterol; 2014 Sep; 20(36):12753-66. PubMed ID: 25278676
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life in the human stomach: persistence strategies of the bacterial pathogen Helicobacter pylori.
    Salama NR; Hartung ML; Müller A
    Nat Rev Microbiol; 2013 Jun; 11(6):385-99. PubMed ID: 23652324
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathogenesis of Helicobacter pylori infection.
    Kusters JG; van Vliet AH; Kuipers EJ
    Clin Microbiol Rev; 2006 Jul; 19(3):449-90. PubMed ID: 16847081
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune response to H. pylori.
    Suarez G; Reyes VE; Beswick EJ
    World J Gastroenterol; 2006 Sep; 12(35):5593-8. PubMed ID: 17007009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunoproteomics of Helicobacter pylori--strategy for improvement of diagnostic tests and vaccine development].
    Roszczenko P; Jagusztyn-Krynicka EK
    Postepy Biochem; 2006; 52(4):424-34. PubMed ID: 17536512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural modifications of Helicobacter pylori lipopolysaccharide: an idea for how to live in peace.
    Chmiela M; Miszczyk E; Rudnicka K
    World J Gastroenterol; 2014 Aug; 20(29):9882-97. PubMed ID: 25110419
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter and gastric malignancies.
    Ferreira AC; Isomoto H; Moriyama M; Fujioka T; Machado JC; Yamaoka Y
    Helicobacter; 2008 Oct; 13 Suppl 1(Suppl 1):28-34. PubMed ID: 18783519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial factors that mediate colonization of the stomach and virulence of Helicobacter pylori.
    Clyne M; Dolan B; Reeves EP
    FEMS Microbiol Lett; 2007 Mar; 268(2):135-43. PubMed ID: 17313591
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Helicobacter pylori on gastric epithelial cells.
    Alzahrani S; Lina TT; Gonzalez J; Pinchuk IV; Beswick EJ; Reyes VE
    World J Gastroenterol; 2014 Sep; 20(36):12767-80. PubMed ID: 25278677
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    Šterbenc A; Jarc E; Poljak M; Homan M
    World J Gastroenterol; 2019 Sep; 25(33):4870-4884. PubMed ID: 31543679
    [No Abstract]   [Full Text] [Related]  

  • 19. Helicobacter pylori and gastric cancer: factors that modulate disease risk.
    Wroblewski LE; Peek RM; Wilson KT
    Clin Microbiol Rev; 2010 Oct; 23(4):713-39. PubMed ID: 20930071
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of Helicobacter pylori virulence factors CagA and VacA on pathogenesis of gastrointestinal disorders.
    Nejati S; Karkhah A; Darvish H; Validi M; Ebrahimpour S; Nouri HR
    Microb Pathog; 2018 Apr; 117():43-48. PubMed ID: 29432909
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 33.